Australia's Island Pharmaceuticals rises on US government collaboration

Shares of Island Pharmaceuticals ILA.AX rise as much as 18.9% to A$0.44, their highest level since February 9

Antiviral drug developer enters cooperative research and development agreement (CRADA) with the US Army Medical Research Institute of Infectious Diseases

Agreement to advance Galidesivir under the U.S. Food and Drug Administration's (FDA) Animal Rule development pathway for the treatment of Marburg virus disease, says co

Galidesivir is a clinical-stage antiviral molecule used against high-priority threats such as Ebola, Marburg, MERS, Zika and Yellow fever, says co

YTD, stock down 4.7%, including the day's move